Alzheimer's & Dementia: Translational Research & Clinical Interventions

Alzheimers Dement

2352-8737

Therapeutic Area

Biochemistry, Bioinformatics, Biology, Clinical Pharmacology, Cytology/Cell Biology, Genetics, Geriatrics, Neurology, Neuropsychiatry, Neuropsychology, Neuroscience, Pathology, Pharmaceutical Development/Drug Development, Pharmaceutical Technology/Drug Technology, Pharmacoeconomics, Psychiatry, Public Health

Bio Chemists, Bioinformaticists, Biologists, Clinical Pharmacologists, Clinicians, Cytologists, Geneticists, Geriatricians, Neurologists, Neuropsychiatrists, Neuropsychologists, Neuroscientists, Pathologists, Pharmaceutical Benefits Managers, Pharmaceutical Scientistists, Pharmacologists, Policy Makers, Psychiatric Nurses, Psychiatrists, Public Health Professionals

Alzheimer's & Dementia: Translational Research & Clinical Interventions (TRCI) is a peer-reviewed, open access journal from the Alzheimer's Association®. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies, validating putative therapies for aging-related chronic brain conditions that affect cognition, motor functions, and other behavioral or clinical symptoms associated with all forms dementia and Alzheimer's disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge: specifically, to translate what is learned at the bench into bedside applications. The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather, an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development. For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions, TRCI will consider only original contributions that include feature length research articles, systematic reviews, meta-analyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimer's disease. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurophysiology, neurology, psychiatry, clinical psychology, bioinformatics, pharmaco-genetics, regulatory issues, health economics, pharmacoeconomics, and public health policy as these apply to preclinical and clinical research on therapeutics. The forms of interventions that are of special interest include, but not limited to: drugs, biologics, devices, and psychotherapeutic, psychosocial, and non-pharmacological modalities. The types of research considered may range from animal model, early discovery and preclinical development to late-stage clinical trials and health technology assessment. Key topics for the journal include a broad array questions or approaches to research such as discovery, related-early protein chemistry, cell biology, mechanistic/exploratory/therapeutic animal models, therapeutic development, clinical pharmacology, preclinical studies, and the application of neuropsychology, clinical ratings, clinical trials methods, neuroimaging, biomarkers, clinical research informatics, and other interdisciplinary approaches relevant to clinical therapeutics and outcomes. Given the growing number of specialized manuscripts in the field of Alzheimer's and dementia research, TRCI provides an expanded platform for the publication of preclinical and clinical translational research. TRCI encourages the submission of manuscripts that describe preclinical research with a potential for clinical application, research from early human experimentation (experimental medicine) that may advance clinical treatment and prevention of Alzheimer pathology, neurodegeneration, and cognitive impairment. Alzheimer's & Dementia: Translational Research & Clinical Interventions will publish manuscripts describing public health research with the potential for application for disease prevention or clinical therapeutics that bridges the laboratory and clinical settings, and laboratory studies of novel therapeutic interventions and new treatment paradigms. TRCI will provide a rapid communication vehicle for manuscripts that focus on translation and clinical research methods, procedures, protocols, analytical approaches and regulatory science.

Alzheimer's Association (AA)

Alzheimer's Association

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Rejection Rate Frequency Author Submission Guidelines